[ad_1] A recent study published on the prepress server bioRxiv* in October 2020 reports the development of a new vaccine based on a simian adenoviral vector obtained from a group C gorilla isolate called GRAd32. This could help accelerate vaccine development. Low seroprevalence for simian adenoviruses Monkey adenoviruses are isolated …
Read More »Results of the Phase 1 trial of the gorilla adenovirus vaccine for COVID-19
